NEW Research Video Series

Could halting CAG expansions be a new treatment for HD?

In this latest edition of the HDYO Research Video Series, we explore the HD Buzz Article that describes somatic instability. "The gene MSH3 is getting a lot of attention in HD research lately. New findings suggest MSH3 lowering could halt CAG repeat expansions, offering a new therapeutic avenue."

To read the complete article, visit: https://en.hdbuzz.net/350

The Research Video Series is sponsors by Teva Pharmaceuticals, uniQure, The Griffin Foundation, Neurocrine Biosciences, Roche and Sage Therapeutics.

Our content is split into different groups. Choose the group that best describes your needs for more information on HD.

x

Support HDYO

HDYO is the only organization who focus solely on supporting young people impacted by HD around the world. Will you help us?